69
Participants
Start Date
June 30, 2013
Primary Completion Date
October 31, 2015
Study Completion Date
October 31, 2015
InterVapor® treatment plus Optimal Medical Therapy
Patients will be treated with the InterVapor System in 1 to 2 segments in the upper lobes of each lung (2 to 3 segments total). Patients will also receive Optimal Medical Therapy. Guidelines for prescribing medical treatment for emphysema are published by the American Thoracic Society (ATS) and the National Heart Lung and Blood Institute/World Health Organization (NHLBI/WHO GOLD workshop summary).
Optimal Medical Therapy
Patients will receive Optimal Medical Therapy. Guidelines for prescribing medical treatment for emphysema are published by the American Thoracic Society (ATS) and the National Heart Lung and Blood Institute/World Health Organization (NHLBI/WHO GOLD workshop summary).
Mater Misericordiae University Hospital, Dublin
Auckland City Hospital, Auckland
Otto-Wagner-Spital, Vienna
The Alfred Hospital, Melbourne
Prince Charles Hospital, Chermside
Royal Adelaide Hospital, Adelaide
Sir Charles Gairdner Hospital, Nedlands
Charite Universitätsmedizin Berlin Campus Mitte, Berlin
Gemeinschaftskrankenhaus Havelhöhe Berlin, Berlin
Asklepios Klinik Harburg, Hamburg
Lungenklinik Hemer, Hemer
Thoraxklinik Heidelberg, Heidelberg
Asklepios Fachkliniken Gauting München, Gauting
Klinikum Nürnberg, Nuremberg
Klinik Schillerhohe, Gerlingen
Universitätsklinik Halle, Halle
Royal Bromptom & Harefield NHS Foundation, London
Uptake Medical Corp
INDUSTRY